Amarin's U.S. Patent Protection For Vascepa [Seeking Alpha]
Amarin Corporation plc - American Depositary Shares, each representing one Ordinary Share (AMRN)
Last amarin corporation plc - american depositary shares, each representing one ordinary share earnings: 4/30 05:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
investor.amarincorp.com/investors
Company Research
Source: Seeking Alpha
In this article, we discuss Amarin's (NASDAQ: AMRN ) U.S. patents on Vascepa ® . From an investor's perspective, the high level story is promising, with protection apparently out to 2030 for 21 of 22 Orange-Book-listed patents. The Vascepa ® patents include 2 formulation patents and 2 method of use patents that appear to be relevant even in view of the possible expanded indication related to the sNDA that Amarin is filing from the Reduce-It trial results. However, as U.S. patent attorneys, we also see that like all issued U.S. patents, there are risks of validity and scope of coverage in the Amarin patent portfolio. The risks are more real in this situation because the active ingredient for Vascepa ® was likely known for related indications before Amarin filed their patent applications, and there is pending generic drug-type litigation related to these patents, facts that are also fairly common for biopharma patents. Below, we provide much more detail about the Amarin V
Show less
Read more
Impact Snapshot
Event Time:
AMRN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
AMRN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
AMRN alerts
High impacting Amarin Corporation plc - American Depositary Shares, each representing one Ordinary Share news events
Weekly update
A roundup of the hottest topics
AMRN
News
- Amarin Announces Results of Annual General Meeting of Shareholders [Yahoo! Finance]Yahoo! Finance
- Amarin Announces Results of Annual General Meeting of ShareholdersGlobeNewswire
- Amarin to Report First Quarter 2024 Financial Results and Host Conference Call on May 1, 2024GlobeNewswire
- Metastatic Liver Cancer Pipeline Insight 2024, Featuring Key Players Oncorus, Sirnaomics, Codiak BioSciences, RemeGen, Amarin, Medivir, AstraZeneca, Amal Therapeutics and Boehringer Ingelheim [Yahoo! Finance]Yahoo! Finance
- Amarin Highlights Key Data Providing Mechanistic Insights into Eicosapentaenoic Acid (EPA) at ACC.24GlobeNewswire
AMRN
Earnings
- 2/29/24 - Beat
AMRN
Sec Filings
- 4/22/24 - Form 8-K
- 4/19/24 - Form 4
- 4/19/24 - Form 4
- AMRN's page on the SEC website